Commodore Capital LP Relay Therapeutics, Inc. Transaction History
Commodore Capital LP
- $1.07 Billion
- Q2 2025
A detailed history of Commodore Capital LP transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 13,350,000 shares of RLAY stock, worth $44.7 Million. This represents 4.31% of its overall portfolio holdings.
Number of Shares
13,350,000Holding current value
$44.7 Million% of portfolio
4.31%Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
216Shares Held
173MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$93.5 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$45 Million0.1% of portfolio
-
Casdin Capital, LLC New York, NY11.4MShares$38.2 Million5.53% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$35.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.38MShares$31.4 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $403M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...